CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Streptococcus pneumoniae +2 morebiological
Likely dose
Streptococcus pneumoniae 0.5 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00569309
NCT00569309N/ACompleted
CompareCT.gov

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation for High-Risk Lymphoma and Myeloma

Ohio State University Comprehensive Cancer Center·interventional·Posted Dec 7, 2007·Updated Mar 12, 2018

In Brief

A clinical study evaluating Streptococcus pneumoniae, laboratory correlative studies, and 1 other intervention for Lymphoma and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

RATIONALE: Vaccines may help the body build an effective immune response to kill cancer cells. Giving vaccine therapy after an autologous stem cell transplant may kill any cancer cells that remain after transplant. PURPOSE: This clinical trial is studying how well vaccine therapy works in treating patients who have undergone autologous stem cell transplant for high-risk lymphoma or multiple myeloma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Small Intestine Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 7, 2007
Enrollment StartDec 12, 2007
Primary CompletionJul 29, 2011
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 18.6 years ago

Interventions

Streptococcus pneumoniaebiological

Patients will receive 0.5 mL Prevnar in the deltoid muscle during weeks 9, 17, and 25 after autologous hematopoietic stem cell transplantation (HSCT)

laboratory correlative studiesother

Approximately 30-mL of blood will be collected and sent to the appropriate research lab(s) for processing.

quality-of-life assessmentother

Responses to Hospital Anxiety and Depression Scale, 9-item brief fatigue inventory 57, brief pain inventory, and the FACT-G. This should take each patient approximately 10-15 minutes to fill out all these surveys per instance.